Abstract
Objective: Due to wide range of biological activities exhibited by pyran derivatives such as antibacterial, antioxidant, anticancer and other activities, we have synthesized and investigated the biological activity of some pyran derivatives. Methods: A series of 4-hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one based azo dyes (IIIa–IIIf) have been synthesized by a conventional diazo coupling reaction. The antioxidant activity was determined via DPPH assay and Antimicrobial activity through disc diffusion test. Results and Discussion: Compound (IIIb) has shown excellent radical scavenging activity with an IC50 value of 20.22 ± 7.36 µg/mL compared to the standard. Furthermore, compounds (IIIc) and (IIId) showed a good antibacterial and antifungal activity against Escherichia coli and Aspergillus niger compared to other prepared azo compounds. Conclusions: We propose that in future, synthesized compounds may act as a promising antimicrobial drugs.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
INTRODUCTION
Azo dyes are the most widely used and oldest class of industrially synthesised organic dyes because of their numerous uses in a variety of industries, including the dyeing of textiles, leather, paper, food, and cosmetic products [1], as well as biomedical research and applications [2, 3]. In high-tech fields like laser [4], photodynamic therapy [5], and dye-sensitized solar cells [6], they are also employed. Azo compounds link two aromatic systems with at least one conjugated azo chromophore (–N=N–) [7–9]. Azole dye synthesis typically takes two steps. Azo dyes are usually synthesised in two steps. The first step is called diazotization, which is the conversion of an aromatic amine to a diazo compound. The second step is called diazo coupling, which is the reaction of the titled diazo compound with a nucleophilic component to produce the corresponding azo dye [10–12].
In both naturally occurring and biologically active compounds, the chromoene moiety is frequently seen as a crucial structural component [13–15]. It has been observed in certain natural alkaloids [17] and is commonly carried out in flavonoids [16, 17]. A unique class of medicinal scaffolds, 2-amino-4H-chromenes is particularly useful among the various types of chromene systems; it is used to treat a variety of conditions, including viral hepatitis [18], Alzheimer’s disease [19], cardiovascular disorders, epilepsy, inflammatory bowel syndrome [20], hypertension, and atherosclerosis [21]. A growing body of research is being done on 2-amino-4Hchromene derivatives with a nitrile group because they are being used to treat inflammatory human diseases like cancer [22], arthritis [23], leukaemia [24], and cancer therapy [25].
These encouraging reports led to the selection of 4-hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one as the coupling component and some diazotized aromatic amines as the diazo component for the reaction. All the synthesised compounds’ structures were verified by 1H NMR, 13C NMR, IR, and LC-MS.
RESULTS AND DISCUSSION
Chemistry
The diazotization route was used to create the six novel pyran-based azo dyes (IIIa–IIIf), which were then characterised using a variety of analytical methods. Scheme 1 depicts the synthetic process, and the supporting information shows the spectra.
Table 1 lists the antioxidant activity of synthetic azo dyes (IIIa–IIIf) against DPPH radicals. Based on the findings, compound (IIIb) exhibited remarkable radical scavenging ability, with an IC50 value of 20.22 ± 7.36 µg/mL in comparison to the reference. Comparing the compounds (IIIb), (IIIe), and (IIIf) to standard, their IC50 values were 108.62 ± 1.0, 130.36 ± 31.69, and 103.36 ± 22.10 µg/mL, respectively, indicating good scavenging activity. Compounds (IIIa) and (IIId) that remained showed reduced activity, with IC50 values of 470.50 ± 41.63 and 314.36 ± 28.96µg/mL, in that order.
Antimicrobial Activity
A disc diffusion method was used to determine the antibacterial activity of all compounds (IIIa–IIIf) against bacterial strains. The results are displayed in Table 2. Comparing compound (IIIc) and (IIId) to amoxicillin, the antibacterial activity results revealed that they had better activity against Escherichia coli. In comparison to amoxicillin, compounds (IIIb) and (IIIf) showed moderate activity against Escherichia coli. Less activity was shown by the remaining compounds (IIIa) and (IIIe).
EXPERIMENTAL
Materials and methods. The reagents and chemicals were bought from Sigma Aldrich. Using KBr pellets, the FTIR-Alpha T Brucker instrument was used to obtain the infrared spectra. Using TMS as the internal reference, 1H and 13C NMR spectra were recorded in DMSO-d6 solvent on a Brucker Avance spectrometer at 400 and 100 MHz, respectively. Water’s SYNAPT G2 QTOF instrument was used to obtain the mass spectra (HRMS).
General procedure for the synthesis of 4-hydroxy6-methyl-5,6-dihydro-2H-pyran-2-one based azo dyes (IIIa–IIIf). The cooled solution of heterocyclic amines (Ia–If) in 8 mL of HCl was mixed dropwise with the ice-cooled solution of NaNO2 in 5 mL of water. During 2 h, the solution was agitated at 0 to 5°C. The ice-cold 4-hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one KOH solution (10%) was mixed with the diazonium mixture dropwise. At the same temperature, the mixture was stirred for an additional two hours. A 10% bicarbonate solution was used to bring the pH down to 6–7. Following the formation of colour, the product was filtered, cleaned with distilled water, and then dried and recrystallized using ethanol diluted with HCl. The corresponding azo dyes (IIIa–IIIf) yielded the product.
3-[(E)-1,3-Benzothiazol-2-yldiazenyl]-4-hydroxy-6methyl-2H-pyran-2-one (IIIa). FT-IR (KBr) νmax, cm–1: 1715 (C=O), 1590 (C=N), 1448 (N=N), 730 (C-S). 1H NMR (400 MHz, DMSO-d6), ppm 3.01 (m, 3H, –CH3), 7.50 (d, J = 8 Hz, 1H, ArH), 7.76 (t, J = 4 Hz, 2H, ArH), 7.92 (t, J = 8 Hz, 2H, ArH), 9.84 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.98, 27.25, 110.30, 109.25, 112.03, 116.07, 123.30, 130.38, 137.20, 139.17, 154.10, 163.50; HRMS: m/z 287.2106 [M]+; Calculated, %: C, 54.35; H, 3.16; N, 14.63; Found, %: C, 54.25; H, 3.01; N, 14.52.
4-Hydroxy-6-methyl-3-[(E)-(7-methyl-1,3-benzothiazol-2-yl)diazenyl]-2H-pyran-2-one (IIIb). FT-IR (KBr) νmax, cm–1: 1710 (C=O), 1585 (C=N), 1440 (N=N), 725 (C–S); 1H NMR (400 MHz, DMSO-d6), ppm: 3.09 (m, 6H, –CH3), 7.52 (d, J = 8 Hz, 1H, ArH), 7.78 (t, J = 4 Hz, 2H, ArH), 7.96 (t, J = 8 Hz, 1H, ArH), 9.88 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.90, 27.15, 110.15, 109.20, 112.25, 116.15, 123.26, 130.23, 137.15, 139.15, 154.16, 163.60; HRMS: m/z 301.3301 [M]+; Calculated, %: C, 55.80; H, 3.68; N, 13.95; Found, %: C, 55.71; H, 3.56; N, 13.84.
3-[(E)-(5-Ethoxy-1,3-benzothiazol-2-yl)diazenyl]4-hydroxy-6-methyl-2H-pyran-2-one (IIIc). FT-IR (KBr) νmax, cm–1: 1720 (C=O), 1580 (C=N), 1442 (N=N), 721 (C–S); 1H NMR (400 MHz, DMSO-d6), ppm: 2.10 (m, 2H, –CH2), 3.09 (m, 3H, –CH3), 3.30 (m, 3H, –CH3), 7.56 (d, J = 8 Hz, 1H, ArH), 7.70 (t, J = 6 Hz, 2H, ArH), 7.92 (t, J = 8 Hz, 1H, ArH), 9.82 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.78, 27.24, 110.20, 109.27, 112.15, 116.24, 123.56, 131.23, 134.15, 137.15, 154.20, 163.24; HRMS: m/z 331.3478 [M]+; Calculated, %: C, 54.37; H, 3.95; N, 12.68; Found, %: C, 54.25; H, 3.84; N, 12.60.
3-[(E)-(5-Chloro-1,3-benzothiazol-2-yl)diazenyl]4-hydroxy-6-methyl-2H-pyran-2-one (IIId). FT-IR (KBr) νmax, cm–1: 1725 (C=O), 1580 (C=N), 1438 (N=N), 740 (C–S); 1H NMR (400 MHz, DMSO-d6), ppm: 3.03 (m, 3H, –CH3), 7.48 (d, J = 8 Hz, 1H, ArH), 7.79 (t, J = 4 Hz, 2H, ArH), 7.90 (t, J = 8 Hz, 1H, ArH), 9.80 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.90, 27.15, 110.20, 109.15, 112.23, 116.47, 123.33, 130.45, 137.78, 139.85, 154.21, 163.41; HRMS: m/z 321.6548 [M]+; Calculated, %: C, 48.53; H, 2.51; N, 11.02; Found, %: C, 48.49; H, 2.45; N, 10.96.
4-Hydroxy-6-methyl-3-[(E)-(5-nitro-1,3-benzothiazol-2-yl)diazenyl]-2H-pyran-2-one (IIIe). FT-IR (KBr) νmax, cm–1: 1712 (C=O), 1582 (C=N), 1444 (N=N), 724 (C–S); 1H NMR (400 MHz, DMSO-d6), ppm: 3.06 (m, 6H, –CH3), 7.47 (d, J = 9 Hz, 1H, ArH), 7.73 (t, J = 6 Hz, 2H, ArH), 7.91 (t, J = 8 Hz, 1H, ArH), 9.89 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.50, 27.21, 110.54, 109.78, 112.23, 116.88, 123.74, 130.86, 137.21, 139.74, 154.23, 163.74; HRMS: m/z 332.4125 [M]+; Calculated, %: C, 46.99; H, 2.43; N, 16.86; Found, %: C, 46.84; H, 2.35; N, 16.74.
3-[(E)-(7-Chloro-1,3-benzothiazol-2-yl)diazenyl]-4hydroxy-6-methyl-2H-pyran-2-one (IIIf). FT-IR (KBr) νmax, cm–1: 1725 (C=O), 1580 (C=N), 1438 (N=N), 740 (C–S); 1H NMR (400 MHz, DMSO-d6), ppm: 3.03 (m, 3H, –CH3), 7.48 (d, J = 8 Hz, 1H, ArH), 7.79 (t, J = 5 Hz, 2H, ArH), 7.90 (t, J = 8 Hz, 1H, ArH), 9.80 (s, 1H, –OH); 13C NMR (100 MHz, DMSO-d6), ppm: 24.90, 27.15, 110.20, 109.15, 112.23, 116.47, 123.33, 130.45, 137.78, 139.85, 154.21, 163.41; HRMS: m/z 321.6548 [M]+; Calculated, %: C, 48.53; H, 2.51; N, 11.02; Found, %: C, 48.49; H, 2.45; N, 10.96.
Antioxidant activity. DPPH radical scavenging activity of the synthesized azo dyes (IIIa–IIIf). The 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) scavenging activity of the synthesized azo dyes (IIIa–IIIf) was investigated. The methodology was followed, albeit slightly modified, from the published report [26]. The compounds were added to test tubes in different concentrations (15.62–1000 μg/mL), and methanol was used to bring the final volume of each test tube to 4 mL. After adding DPPH in methanol (0.004%, 3 mL) to the mixtures, they were incubated for approximately 24 h at 37°C and then for 30 min in the dark. To measure the absorbance at 517 nm, a UV-Visible spectrophotometer (Shimadzu UV-1800, Japan) was utilized. A blank consisting of 95% methanol was taken, and ascorbic acid in the same volume was used as a control. The test was run three times, and the results were reported as an IC50.
Antimicrobial activity. Using the disc diffusion method, the antimicrobial activity of synthetic compounds (IIIa–IIIf) was investigated [27]. 1 mL of lag phase bacterial strains, including Staphylococcus aureus and Escherichia coli, was added to the tubes as an inoculant. Penicillin chrysogenum and Aspergillus niger were two examples of the fungal strains used. Potato dextrose agar medium was used for fungi, and sterile nutrient agar medium was used for the growth of bacteria. Various quantities (10–100 mg) of synthesized conjugates (IIIa–IIIf) were added to the correspondingly labelled discs and combined with DMSO. The bacterial plate was then incubated for 24 h at 37°C and for 48 h for fungi at 27°C. For every compound, the zone of inhibition was measured.
CONCLUSIONS
The goal of this work was to create new azo dyes based on 4-hydroxy-6-methyl-5,6-dihydro-2H-pyran2-one. The spectroscopic techniques of 1H NMR, LCMS, and FT-IR were used to confirm the structures of azo dyes. Additionally, the produced derivatives underwent screening for the ability of synthetic azo dyes to scavenge DPPH radicals was used to assess their antioxidant potential. Upon DPPH scavenging activity, all synthesized compounds demonstrated good efficacy, with IC50 values ranging from 20.22 ± 7.36 to 470.50 ± 41.63 µg/mL. Compounds (IIIc) and (IIId) demonstrated strong antibacterial and antifungal activity against Escherichia coli and Aspergillus niger, according to the results of the antimicrobial activity tests. The remaining compounds’ antifungal and antibacterial activity was lower.
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
Keri, R.S., Patil, M.R., Patil, S.A., and Budagumpi, S., Eur. J. Med. Chem., 2015, vol. 89, pp. 207–251. https://doi.org/10.1016/j.ejmech.2014.10.059
Nandeshwarappa, B.P., Chandrashekharappa, S., Sadashiv, S.O., Patil S.J., and Onkarappa, H.S., Chem. Data Collect., 2021, vol. 33, Article ID: 100716. https://doi.org/10.1016/j.cdc.2021.100716
Manjunatha, B. and Bodke. Y.D., J. Mol. Struct., 2021, vol. 1244, Article ID: 130933. https://doi.org/10.1016/j.molstruc.2021.130933
Direkel, S., Süleymanoglu, N., Eyduran, F., Tileklioglu, E., Ertabaklar, H., and Karaman, U., Russ. J. Bioorg. Chem., 2023, vol. 49, pp. 1408–1421. https://doi.org/10.1134/S1068162023060213
Lashin, W.H., Nassar, I.F., El Farargy, A.F., and Abdelhamid, A.O., Russ. J. Bioorg. Chem., 2020, vol. 46, pp. 1074–1086. https://doi.org/10.1134/S1068162020060163
Chandrashekharappa, S., Sadashiv, S.O., Patil, S.J., and Nandeshwarappa, B.P., Pharm. Chem. J., 2022, vol. 56, pp. 638–644. https://doi.org/10.1002/slct.202102619
Gopalakrishnan, A.K., Angamaly, S.A., and Velayudhan, M.P.,ChemistrySelect, 2021, vol. 6, pp. 10918–10947. https://doi.org/10.1002/slct.202102619
Chung, K.T., J. Environ. Sci. Health C, 2016, vol. 34, pp. 233–261. https://doi.org/10.1080/10590501.2016.1236602
Mekkawi, D.E. and Abdel-Mottaleb, M.S.A., Int. J. Photoenergy, 2005, vol. 7, pp. 95–101. https://doi.org/10.1155/S1110662X05000140
Bafana, A., Devi, S.S., and Chakrabarti, T., Environ. Rev., 2011, vol. 19, pp. 350–370. https://doi.org/10.1139/a11-018
Yazdanbakhsh, M.R. and Mohammadi, A., J. Mol. Liq., 2009, vol. 148, pp. 35–39. https://doi.org/10.1016/j.molliq.2009.06.001
Shawali, A.S., Harb, N.M.S., and Badahdah, K.O., J. Heterocycl. Chem., 1985, vol. 22, pp. 1397–1403. https://doi.org/10.1002/jhet.5570220555
De Simone, R.W., Currie, K.S., Mitchell, S.A., Darrow, J.W., and Pippin, D.A., Comb. Chem., 2004, vol. 7, pp. 473–493. https://doi.org/10.2174/1386207043328544
Yadav, C.K., Nandeshwarappa, B.P., and Pasha K.M.M., Chim. Techno Acta, 2023, vol. 10, Article ID: 202310110. https://doi.org/10.15826/chimtech.2023.10.1.10
Attaur, R., Choudhary, MI., Shaheen, F., Ahmad, M., and Khan, S.N., Pat. Appl., 2008, Article ID: 269510. https://doi.org/10.1016/j.crci.2015.02.005
Yadav, C.K., Manjunatha, B., Mussuvir Pasha, K.M., Samuel, J., and Nandeshwarappa, B.P., ChemistrySelect, 2023, vol. 8, Article ID: e202301432. https://doi.org/10.1002/slct.202301432
Ishikaw, T., Kumamoto, T., Shimokawa, S., Takashi, M., Higuchi, Y., Chaichantipyuth, C., and Chansakaow, S., Nat. Prod. Res., 2013, vol. 27, pp. 371–378. https://doi.org/10.1080/14786419.2012.695370
Maruthesh, H., Katagi, M.S., and Nandeshwarappa, B.P., Russ. J. Bioorg. Chem., 2023, vol. 49, pp. 1059–1067. https://doi.org/10.1134/S1068162023050138
Maruthesh, H., Katagi, M.S., Samuel, J., Aladakatti, R.H., and Nandeshwarappa, B.P., Russ. J. Bioorg. Chem., 2023, vol. 49, pp. 1422–1437. https://doi.org/10.1134/S1068162023060225
Nandeshwarappa, B.P., Chandrashekharappa, S., and Prakash, G.K., Chem. Dat. Collect., 2020, vol. 29, Article ID: 100534. https://doi.org/10.1016/j.cdc.2020.100446
Yahagi, T., Daikonya, A., and Kitanaka, S., Chem. Pharm. Bull., 2012, vol. 60, pp. 129–136. https://doi.org/10.1248/cpb.60.129
Chicca, A., Tebano, M., Adinolfi, B., Ertugrul, K., Flamini, G., and Nieri, P., Eur. J. Med. Chem., 2011, vol. 46, pp. 3066–3070. https://doi.org/10.1016/j.ejmech.2011.03.011
Kawamura, N., Kinoshita, N., Sawa, R., Takahashi, Y., Sawa, T., Naganawa, H., Hamada, M., and Takeuchi, T., J. Antibiotics, 1996, vol. 49, pp. 706–709. https://doi.org/10.7164/antibiotics.49.706
Maruthesh, H., Katagi, M.S., and Nandeshwarappa, B.P., Curr. Chem. Lett., 2023, vol. 12, pp. 759–768. https://doi.org/10.5267/j.ccl.2023.4.005
Johansen, L., Owens, C., Mawhinney, C., Chappell, T.W., Brown, A.T., Frank, M.G., and Altmeyer, R., Pat. Appl., 2008, vol. 24, Article ID: 33466. https://doi.org/10.1016/j.crci.2015.02.005
Manjunatha, B., Bodke, Y.D., Kumaraswamy, H.M., Meghana, P., and Nagaraja, O., J. Mol. Struct., 2022, vol. 1249, Article ID: 131642. https://doi.org/10.1016/j.molstruc.2021.131642
Veeranna, N.P., Bodke, Y.D., Basavaraju, M., and Krishnamurthy, P., Nucleosid. Nucleotid. Nucl. Acids, 2022, vol. 42, pp. 1–15. https://doi.org/10.1080/15257770.2022.2127765
Author information
Authors and Affiliations
Contributions
The author KYC–methodology, investigation, writing–original draft; the author MB–writing and analysis; the author NBP–investigation, supervision, and editing.
All authors participated in the discussions.
Corresponding author
Ethics declarations
This article does not contain any studies involving patients or animals as test objects.
Informed consent was not required for this article. No conflicts of interest was declared by the authors.
Additional information
Publisher's Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Yadav, C.K., Manjunatha, B. & Nandeshwarappa, B.P. Synthesis, Characterization, and Biological Studies of Novel 4-Hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one Based Azo Dyes. Russ J Bioorg Chem 50, 1512–1518 (2024). https://doi.org/10.1134/S1068162024040320
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162024040320